A Novel Six Consecutive Monthly Doses of Palivizumab Prophylaxis Protocol for the Prevention of Respiratory Syncytial Virus Infection in High-Risk Preterm Infants in Taiwan

BACKGROUND: Respiratory syncytial virus (RSV) circulates year round in Taiwan. A novel six consecutive monthly doses of palivizumab for RSV prevention protocol has been approved for high risk preterm infants since December 2010. This study aimed to determine the clinical effectiveness and safety of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, Hsin, Hsu, Chyong-Hsin, Chang, Jui-Hsing, Chiu, Nan-Chang, Hung, Han-Yang, Kao, Hsin-An, Weng, Li-Chuan, Huang, Fu-Yuan, Chiu, Yu-Ying, Chang, Luan-Yin, Huang, Li-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074126/
https://www.ncbi.nlm.nih.gov/pubmed/24971565
http://dx.doi.org/10.1371/journal.pone.0100981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074126/
https://www.ncbi.nlm.nih.gov/pubmed/24971565
http://dx.doi.org/10.1371/journal.pone.0100981

Ejemplares similares